Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-28

Clinical Trial Update: Efficacy of Roflumilast in the Treatment of Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on roflumilast for psoriasis has completed evaluating efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Psoriasis | Phase 2 | Status: COMPLETED